Market Overview

Top 4 Small-Cap Stocks In The Biotechnology Industry With The Highest Cash

Related DNDN
Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats Street View
Dendreon Says Prelim. Data from LT Phase II STAND Study Will Be Presented at EAU Congress, Will Show Immune Responses with PROVENGE Enhanced, Sustained
Related VPHM
US Stock Futures Signal Flat Start On Wall Street
Shire Extends Tender Offer for ViroPharma to Thursday, January 9, 2014

Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of cash.

Dendreon Corp (NASDAQ: DNDN) had $497.54 million in total cash and $573.82 million in total debt for the latest quarter.

ViroPharma Inc (NASDAQ: VPHM) had $473.36 million in total cash and $155.46 million in total debt for the latest quarter.

Momenta Pharmaceuticals Inc (NASDAQ: MNTA) had $382.26 million in total cash and no debt for the latest quarter.

Nektar Therapeutics (NASDAQ: NKTR) had $382.11 million in total cash and $228.85 million in total debt for the latest quarter.

Posted-In: Biotechnology Industry highest cash small-capTrading Ideas

 

Most Popular

Related Articles (DNDN + MNTA)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free